2015•Annals of Emergency MedicineRequires access

262 Initial Experience With Idarucizumab in Dabigatran-Treated Patients Presenting With Acute Traumatic Injuries: Interim Results From the RE-VERSE AD Study

CV Pollack, Fredrik I. Gruenenfelder, John W. Eikelboom, Elaine Hylek, Mackenzie Mills, Frank William Sellke, Pieter Willem Kamphuisen, Paul A. Reilly, J. Kreuzer, Jeffrey Ian Weitz

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Dabigatran, Idarucizumab, Medicine, Prothrombin complex concentrate, Warfarin, Direct thrombin inhibitor, Coagulopathy, Emergency department